Venous thromboembolic disease in childhood

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 4, 2003, Pages 391-403

  Van Ommen, C Heleen ^a   Peters, Marjolein ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Anticoagulation; Outcome; Pediatrics; Thrombophilia; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CARDIOLIPIN ANTIBODY; FIBRINOLYTIC AGENT; HEPARIN; LIPOPROTEIN A; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PLASMINOGEN ACTIVATOR; PROTEIN C; PROTEIN S; PROTHROMBIN; STREPTOKINASE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTICOAGULANT THERAPY; CENTRAL VENOUS CATHETER; CHILDHOOD DISEASE; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FOLLOW UP; HUMAN; KIDNEY VEIN THROMBOSIS; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PORTAL VEIN; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT DISEASE; REVIEW; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT OUTCOME; VEIN THROMBOSIS;

CHILD; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; PREVALENCE; THROMBOEMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 0041363279     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42589     Document Type: Review

References (148)

1. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-160
2. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994;83:1251-1257
3. van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HSA, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001;139:676-681
4. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-F167
5. Byard RW, Cutz E. Sudden and unexpected death in infancy and childhood due to pulmonary thromboembolism. An autopsy study. Arch Pathol Lab Med 1990;114:142-144
6. Jones RH, Sabiston DCJ. Pulmonary embolism in childhood. Monogr Surg Sci 1966;3:35-51
7. Marsh D, Wilkerson SA, Cook LN, Pietsch JB. Right atrial thrombus formation screening using two-dimensional echocardiograms in neonates with central venous catheters. Pediatrics 1988;81:284-286
8. Mehta S, Connors AFJ, Danish EH, Grisoni E. Incidence of thrombosis during central venous catheterization of newborns: a prospective study. J Pediatr Surg 1992;27:18-22
9. Tanke RB, Van Megen R, Daniëls O. Thrombus detection on central venous catheters in the neonatal intensive care unit. Angiology 1994;45:477-480
10. Wever MLG, Liem KD, Geven WB, Tanke RB. Urokinase therapy in neonates with catheter related central venous thrombosis. Thromb Haemost 1995;73:180-185
11. Roy M, Turner-Gomes S, Gill G, Way C, Mernagh J, Schmidt B. Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters. J Pediatr 2002;140:131-134
12. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 1995;126:50-54
13. Shefler A, Gillis J, Lam A, O'Connell AJ, Schell D, Lammi A. Inferior vena cava thrombosis as a complication of femoral vein catheterisation. Arch Dis Child 1995;72:343-345
14. Talbott GA, Winters WD, Bratton SL, O'Rourke PP. A prospective study of femoral catheter-related thrombosis in children. Arch Pediatr Adolesc Med 1995;149:288-291
15. Glaser DW, Medeiros D, Rollins N, Buchanan GR. Catheter-related thrombosis in children with cancer. J Pediatr 2001;138:255-259
16. Virchow R. Phlogose und Thrombose im Gefässsystem. In: Virchow R, ed. Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt, Germany: Von Meidinger Sohn; 1856:458-636
17. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000;47:763-766
18. Gurgey A, Aslan D. Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 2001;23:159-164
19. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;96:939-943
20. Conte FA, Grumbach MM. Estrogen use in children and adolescents: a survey. Pediatrics 1978;62:1091-1097
21. Weimann E, Brack C. Severe thrombosis during treatment with ethinylestradiol for tall stature. Horm Res 1996;45:261-263
22. Werder EA, Waibel P, Sege D, Flury R. Severe thrombosis during oestrogen treatment for tall stature. Eur J Pediatr 1990;149:389-390
23. Wettenhall HN, Cahill C, Roche AF. Tall girls: a survey of 15 years of management and treatment. J Pediatr 1975;86:602-610
24. van Ommen CH, Fijnvandraat K, Vulsma T, Delemarre-Van De Waal HA, Peters M. Acquired protein S deficiency caused by estrogen treatment of tall stature. J Pediatr 1999;135:477-481
25. Al-Ismail S, Collins P, Najib R, James-Ellison M, O'Hagan M. Postinfection purpura fulminans in a patient heterozygous for prothrombin G20210A and acquired protein S resistance. Pediatr Hematol Oncol 1999;16:561-564
26. D'Angelo A, Della Valle P, Crippa L, Pattarini E, Grimaldi LM, D'Angelo SV. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med 1993;328:1753-1757
27. Josephson C, Nuss R, Jacobson L, et al. The varicella-autoantibody syndrome. Pediatr Res 2001;50:345-352
28. Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr 1995;127:355-363
29. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996;128:319-323
30. van Ommen CH, Van Wijnen M, De Groot FG, Van Der Horst CMAM, Peters M. Postvaricella purpura fulminans caused by acquired protein S deficiency resulting from antiprotein S antibodies: search for the epitopes. J Pediatr Hematol Oncol 2002;24:413-416
31. Schlegel N. Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost 1997;23:271-280
32. Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J. Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand 1986;75:804-810
33. Fiumara A, Barone R, Buttitta P, et al. Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type I. Thromb Haemost 1996;76:502-504
34. Iijima K, Murakami F, Nakamura K, et al. Hemostatic studies in patients with carbohydrate-deficient glycoprotein syndrome. Thromb Res 1994;76:193-198
35. Okamoto N, Wada Y, Kobayashi M, et al. Decreased blood coagulation activities in carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 1993;16:435-440
36. Van Geet C, Jaeken J. A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome. Pediatr Res 1993;33:540-541
37. Stibler H, Jaeken J, Kristiansson B. Biochemical characteristics and diagnosis of the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand Suppl 1991;375:21-31
38. Young G, Driscoll MC. Coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome: case report and review of the literature. Am J Hematol 1999;60:66-69
39. Funk M, Becker S, Pötzsch B, Kreuz W, Böhles H. Thrombophilia in a child with CDG-syndrome type I. Thromb Haemost 1995;74:1199-1200
40. Jaeken J, Matthijs G, Carchon H, Van Schaftingen E. Defects of n-glycan synthesis. In: Scriver CR, Beandet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001:1601-1622
41. Stibler H, Holzbach U, Tengborn L, Kristiansson B. Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type I. Blood Coagul Fibrinolysis 1996;7:118-126
42. Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, Hillege HL, Bom VJ, Van Der Meer J. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990;336:1087-1090
43. Jahangiri M, Shore D, Kakkar V, Lincoln C, Shinebourne E. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 1997;113:989-992
44. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 1999;82:40-46
45. Jahangiri M, Ross DB, Redington AN, Lincoln C, Shinebourne EA. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg 1994;58:1409-1413
46. Monagle P, Karl TR. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002;5:36-47
47. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: part 1. Thromb Haemost 1996;76:651-662
48. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-1173
49. Bonduel M, Hepner M, Sciuccati G, Torres AF, Pieroni G, Frontroth JP. Prothrombotic abnormalities in children with venous thromboembolism. J Pediatr Hematol Oncol 2000;22:66-72
50. Bonduel M, Hepner M, Sciuccati G, et al. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb Haemost 2002;87:972-977
51. Ehrenforth S, Junker R, Koch HG, et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. Eur J Pediatr 1999;158(Suppl 3):S97-104
52. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999;19:2568-2572
53. Kosch A, Junker R, Kurnik K, et al. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res 2000;99:531-537
54. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child 1999;81:176-178
55. Nowak-Göttl U, Junker R, Kreuz W, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001;97:858-862
56. Salonvaara M, Riikonen P, Kekomäki R, Heinonen K. Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr 1999;88:642-646
57. Schobess R, Junker R, Auberger K, Münchow N, Budach S, Nowak-Göttl U. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation. Eur J Pediatr 1999;158(Suppl 3):S105-S108
58. Cattaneo M. Hyperhomocysteinemia and thrombosis. Lipids 2001;36(Suppl):S13-S26
59. Libourel EJ, Bank I, Meinardi JR, et al. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism. Haematologica 2002;87:1068-1073
60. Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000;342:696-701
61. Nowak-Göttl U, Junker R, Hartmeier M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999;100:747-748
62. Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002;113:636-642
63. Van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000;95:3678-3682
64. Van Tilburg NH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 2000;95:2855-2859
65. von Depka M, Nowak-Göttl U, Eisert R, et al. Increased lipoprotein(a) levels as an independent risk factor for venous thromboembolism. Blood 2000;96:3364-3368
66. Manco-Johnson MJ, Grabowski EF, Hellgreen M, et al. Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost 2002;88:155-156
67. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-907
68. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 2001;345:165-169
69. Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 2001;119:344S-370S
70. van Ommen CH. Venous Thromboembolic Disease in Childhood. Epidemiology, Risk Factors and Outcome [master's thesis]. Amsterdam, The Netherlands: Univ of Amsterdam; 2002:103-113
71. Tormene D, Simioni P, Prandoni P, et al. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood 2002;100:2403-2405
72. Mulvihill SJ, Fonkalsrud EW. Complications of superior versus inferior vena cava occlusion in infants receiving central total parenteral nutrition. J Pediatr Surg 1984;19:752-757
73. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatr 2000;136:653-658
74. Campbell RM, Benson LN, Williams WW, Adatia I. Chylopericardium after cardiac operations in children. Ann Thorac Surg 2001;72:193-196
75. Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter. J Pediatr 1998;132:1064-1066
76. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter-related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133:770-776
77. Andrew M, Brooker LA. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996;10:88-99
78. Bökenkamp A, von Kries R, Nowak-Göttl U, Göbel U, Hoyer PF. Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr 2000;159:44-48
79. Mocan H, Beattie TJ, Murphy AV. Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol 1991;5:45-49
80. Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983;2:1165-1168
81. Mahasandana C, Suvatte V, Chuansumrit A, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990;117:750-753
82. Baselga E, Drolet BA, Esterly NB. Purpura in infants and children. J Am Acad Dermatol 1997;37:673-705
83. Schwartz DS, Gettner PA, Konstantino MM, et al. Umbilical venous catheterization and the risk of portal vein thrombosis. J Pediatr 1997;131:760-762
84. Sieders E, Peeters PM, Tenvergert EM, et al. Early vascular complications after pediatric liver transplantation. Liver Transplant 2000;6:326-332
85. van't Riet M, Burger JW, Van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg 2000;87:1229-1233
86. Yamanaka J, Lynch SV, Ong TH, et al. Surgical complications and long-term outcome in pediatric liver transplantation. Hepatogastroenterology 2000;47:1371-1374
87. Barron TF, Gusnard DA, Zimmerman RA, Clancy RR. Cerebral venous thrombosis in neonates and children. Pediatr Neurol 1992;8:112-116
88. Deveber G, Andrew M. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417-423
89. Rivkin MJ, Anderson ML, Kaye EM. Neonatal idiopathic cerebral venous thrombosis: an unrecognized cause of transient seizures or lethargy. Ann Neurol 1992;32:51-56
90. Shevell MI, Silver K, O'Gorman AM, Watters GV, Montes JL. Neonatal dural sinus thrombosis. Pediatr Neurol 1989;5:161-165
91. Derish MT, Smith DW, Frankel LR. Venous catheter thrombus formation and pulmonary embolism in children. Pediatr Pulmonol 1995;20:349-354
92. van Ommen CH, Heijboer H, Groothoff JW, Teeuw R, Aronson DC, Peters M. Persistent tachypnea in children: keep pulmonary embolism in mind. J Pediatr Hematol Oncol 1998;20:570-573
93. Buck JR, Connors RH, Coon WW, Weintraub WH, Wesley JR, Coran AG. Pulmonary embolism in children. J Pediatr Surg 1981;16:385-391
94. Bernstein D, Coupey S, Schonberg SK. Pulmonary embolism in adolescents. Am J Dis Child 1986;140:667-671
95. Desai MH, Linares HA, Herndon DN. Pulmonary embolism in burned children. Burns 1989;15:376-380
96. Matthew DJ, Levin M. Pulmonary thromboembolism in children. Intensive Care Med 1986;12:404-406
97. Lensing AW, Prandoni P, Brandjes D, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989;320:342-345
98. Male C, Chair P, Ginsberg JS, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic antithrombin replacement in kids with ALL treated with asparaginase. Thromb Haemost 2002;87:593-598
99. Casey SO, Alberico RA, Patel M, et al. Cerebral CT venography. Radiology 1996;198:163-170
100. Connor SE, Jarosz JM. Magnetic resonance imaging of cerebral venous sinus thrombosis. Clin Radiol 2002;57:449-461
101. Dormont D, Anxionnat R, Evrard S, Louaille C, Chiras J, Marsault C. MRI in cerebral venous thrombosis. J Neuroradiol 1994;21:81-99
102. Medlock MD, Olivero WC, Hanigan WC, Wright RM, Winek SJ. Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery 1992;31:870-876
103. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983;98:891-899
104. Mills SR, Jackson DC, Older RA, Heaston DK, Moore AV. The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series. Radiology 1980;136:295-299
105. van Strijen MJ, De Monye W, Schiereck J, et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study or 510 patients. Ann Intern Med 2003;138:307-314
106. Gleason MM, White MG, Myers JL. Echocardiographic diagnosis of pulmonary embolism in childhood. J Am Soc Echocardiogr 1995;8:100-102
107. Cheriex EC, Sreeram N, Eussen YF, Pieters FAA, Wellens HJJ. Cross-sectional Doppler echocardiography as the initial technique for the diagnosis of acute pulmonary embolism. Br Heart J 1994;72:52-57
108. Häusler M, Hübner D, Delhaas T, Mühler EG. Long-term complications of inferior vena cava thrombosis. Arch Dis Child 2001;85:228-233
109. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133:770-776
110. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000;47:763-766
111. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000;160:761-768
112. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7
113. Marzinotto V, Choi M, Massicotte MP, Chan AKC, Andrew M. Post-thrombotic syndrome in children with previous deep vein thrombosis. Thromb Haemost 2001;78(Suppl):OC962 (Abst)
114. Brandjes DPM, Büller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-762
115. Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr 2000;136:446-453
116. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701-707
117. Palmer AJ, Koppenhagen K, Kirchhof B, Weber U, Bergemann R. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials. Haemostasis 1997;27:75-84
118. Seipelt RG, Franke A, Vazquez-Jimenez JF, et al. Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. Ann Thorac Surg 2002;74:556-562
119. van Ommen CH, Ottenkamp J, Lam J, et al. The risk of post-thrombotic syndrome in children with congenital heart disease. J Pediatr 2002;141:582-586
120. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001;119:64S-94S
121. Andrew M, Marzinotto V, Brooker LA, et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 1994;71:265-269
122. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 1999;94:3007-3014
123. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119:8S-21S
124. Marzinotto V, Monagle P, Chan A, et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000;21:347-352
125. Massicotte P, Marzinotto V, Vegh P, Adams M, Andrew M. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr 1995;127:389-394
126. Beitzke A, Zobel G, Zenz W, Gamillscheg A, Stein JI. Catheter-directed thrombolysis with recombinant tissue plasminogen activator for acute pulmonary embolism after Fontan operation. Pediatr Cardiol 1996;17:410-412
127. Knöfler R, Dinger J, Kabus M, et al. Thrombolytic therapy in children - clinical experiences with recombinant tissue-plasminogen activator. Semin Thromb Hemost 2001;27:169-174
128. Kothari SS, Varma S, Wasir HS. Thrombolytic therapy in infants and children. Am Heart J 1994;127:651-657
129. Rehan VK, Cronin CM, Bowman JM. Neonatal portal vein thrombosis successfully treated by regional streptokinase infusion. Eur J Pediatr 1994;153:456-459
130. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics 1995;96:291-294
131. Aschka I, Aumann V, Bergmann F, et al. Prevalence of factor V Leiden in children with thrombo-embolism. Eur J Pediatr 1996;155:1009-1014
132. Sifontes MT, Nuss R, Jacobson LJ, Griffin JH, Manco-Johnson MJ. Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr 1996;128:324-328
133. Nowak-Göttl U, Dubbers A, Kececioglu D, et al. Factor V Leiden, protein C, and lipoprotein(a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997;131:608-612
134. Uttenreuther-Fischer MM, Vetter B, Hellmann C, et al. Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 1997;156:277-281
135. Sifontes MT, Nuss R, Hunger SP, Waters J, Jacobson LJ, Manco-Johnson M. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis. Am J Hematol 1998;57:29-32
136. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998;133:777-781
137. Kohlhase B, Vielhaber H, Kehl HG, Kececioglu D, Koch HG, Nowak-Göttl U. Thromboembolism and resistance to activated protein C in children with underlying cardiac disease. J Pediatr 1996;129:677-679
138. Seixas CA, Hessel G, Siqueira LH, Machado TFGS, Gallizoni AM, Annichino-Bizzacchi JM. Study of hemostasis in pediatric patients with portal vein thrombosis. Haematologica 1998;83:955-956
139. Dubuisson C, Boyer-Neumann C, Wolf M, Meyer D, Bernard O. Protein C, protein S and antithrombin III in children with portal vein obstruction. J Hepatol 1997;27:132-135
140. Fabri D, Belangero VMS, Annichino-Bizzacchi JM, Arruda VR. Inherited risk factors for thrombophilia in children with nephrotic syndrome. Eur J Pediatr 1998;157:939-942
141. Nowak-Göttl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999;93:1595-1599
142. Münchow N, Kosch A, Schobess R, Junker R, Auberger K, Nowak-Göttl U. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis. Eur J Pediatr 1999;158(suppl):S109-S112
143. Wermes C, von Depka P, Lichtinghagen R, Barthels M, Welte K, Sykora KW. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. Eur J Pediatr 1999;158(Suppl):S143-S146
144. Knöfler R, Siegert E, Lauterbach I, et al. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy - impact of central venous lines. Eur J Pediatr 1999;158(Suppl):S147-S150
145. Heller C, Schobess R, Kurnik K, et al. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. Br J Haematol 2000;111:534-539
146. Mauz-Körholz C, Junker R, Gobel U, Nowak-Göttl U. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols). Thromb Haemost 2000;83:840-843
147. Atalay S, Akar N, Tutar HE, Yilmaz E. Factor V 1691 G-A mutation in children with intracardiac thrombosis: a prospective study. Acta Paediatr 2002;91:168-171
148. Seixas CA, Hessel G, Ribeiro CC, Arruda VR, Annichino-Bizzacchi JM. Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost 1997;77:258-261